Dr. Ana C. Botero, MD

Dr. Botero practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Botero's NPI, 1225034457, was assigned on June 22, 2005. Dr. Botero graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1985. Dr. Botero holds Florida license ME93178.

Dr. Botero's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Botero's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group Oncology. Dmand AI also links Dr. Botero to 1 more breast imaging center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Botero practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Botero's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Botero is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Botero's licenses on file in 2 states: Florida and Missouri.

Dmand AI lists bone cancer radiation, breast cancer radiation, cervical cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Botero treats.

CMS data shows 731 Medicare services from Dr. Botero across 10 procedure codes in 2024, for 87 Medicare patients. Medicare paid $54,267 for them.

CMS counts 87 Medicare patients who saw Dr. Botero in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Botero's median patient age at 64, with 76% women.

In 2024, Dr. Botero wrote 60 Medicare Part D claims for 33 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $240 in total drug cost. In 2019, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Botero for performance year 2024, reported as part of a group. Dr. Botero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Botero as offering telehealth.

Dmand AI links 1 paper to Dr. Botero in 2017. Dr. Botero's most frequent co-authors are Federico Bengoa, MD, Aurelio B. Castrellon, MD and Steven M. Nguyen, MD.

CMS Open Payments shows 91 general payments to Dr. Botero from 30 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 41% of the total. Accuray Incorporated paid the most, $19,880.

Dr. Botero graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1985.

Dr. Botero is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.